Introduction
Human 7 S yG-immunoglobulins (IgG) are composed of dissimilar polypeptide chains of different molecular weights called heavy and light chains. The light chains are divided into two major antigenic types, Type-I or kappa and Type II or lambda. Circulating IgG contains types kappa and lambda in approximately a 2: 1 ratio (kappa: lambda) (1, 2) , and specific antibodies also contain both types in varying ratios (3) .
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with autoimmune hemolytic anemia. In most cases these autoantibodies did not show the usual 2: 1 ratio, but consisted of either type kappa or type lambda.
The localization of IgG and fl1c-globulin on the glomeruli of patients with various forms of glomerulonephritis suggests that immune mechanisms play a role in these diseases. Although the exact pathogenesis has not been defined, certain diseases, such as acute poststreptococcal glomerulonephritis, are similar morphologically to experimental antigen-antibody complex disease (5) . The presence of IgG on the glomeruli could also reflect localization of antibody having specificity for the kidney itself, or might even represent deposition of aggregated y-globulin similar to that occurring in the experimental animal (6) .
To investigate further the mechanisms involved in the glomerular deposition of IgG in patients with diffuse renal disease, we determined the light chain types in these deposits by immunofluorescent methods. In addition, we estimated serum kappa: lambda ratios in half of these patients to correlate them with the kappa and lambda chain deposition in the kidney. We found that the glomerular deposition tended to be predominantly kappa or lambda and to be independent of the kappa: lambda ratio of the circulating immunoglobulin pool.
Methods
Human light chains of types kappa and lambda were obtained in the form of Bence Jones proteins from the urine of patients with multiple myeloma.1 The light chains were purified by gel filtration through Sephadex G-100 and by ion exchange chromatography with DEAE Sephadex A-50 according to the method of Bernier and Putnam (7) . The isolated proteins gave single peaks and had observed sedimentation coefficients of 3.1 (kappa) and 2.8 (lambda) on analytical ultracentrifugation; single lines were seen on immunoelectrophoresis with rabbit antiserum to human IgG and whole human serum. Antisera against the kappa and lambda antigens were prepared by injecting 1.0 mg of antigen emulsified in complete Freund's adjuvant 2 into the heel pads and at multiple sites subcutaneously in rabbits. Intravenous boosters of 1.0 mg were administered after 1 month, and the animals were bled 2 weeks later. in Table I Table I , grouped by disease. The results of the fluorescent staining for IgG, kappa chains, and lambda chains are tabulated, as is the serum kappa: lambda ratio.
Sixteen biopsies had an intensity of fluorescent staining in the glomeruli that was greater with antikappa than with antilambda, and in 7 of these there was no demonstrable fluorescence with antilambda (Figures 1-3) . Thirteen biopsies had fluorescent staining that was greater with antilambda than with antikappa, and 6 of them showed no significant kappa staining. Three biopsies had approximately equal fluorescence with both antisera. In no case was the intensity of staining with fluorescein-conjugated antilight chain antisera greater than the intensity of staining with antiIgG, and in most cases it was somewhat less. There was no correlation between the type of renal disease and the type of light chain staining. Since no difference in location of fluorescent material could be found with any of the antisera that gave staining of sufficient intensity, it appeared likely that the same immune deposits were being stained by the different antisera. The fluorescence changed somewhat in the two patients who had serial biopsies. In Patient 4, the initial biopsy stained both waith antikappa and antilambda (Figure 4) , but in the second biopsy ( Figures 5 and 6 ) there was no lambda chain fluorescence although the glomeruli retained their fluorescence with antikappa. In Patient 25 the fluorescence for both kappa and lambda chains persisted in the second biopsy but had diminished slightly.
The serum kappa-lambda ratios showed no correlation with the degree of fluorescence observed on the kidney when antikappa or antilambda sera were used, nor was there any correlation with the type of renal disease. The kappa: lambda ratios obtained in this study are significantly higher than normal values previously reported, but are similar to those observed in similar diseases (2) . The average serum kappa: lambda ratio for the group as a whole was 3.74. The average kappa: lambda ratio of the serum from patients whose biopsies showed predominantly fluorescent staining for kappa chains was 3.88. For those whose biopsies showed predominantly fluorescent staining for lambda chains, the average kappa: lambda ratio was 3.63, and for those with approximately equal kappa and lambda staining the value was 3.79. These ratios are not significantly different.
Discussion
The immunoglobulin deposited on basement membranes in experimental renal disease has been shown to be antibody complexed with antigen and complement, heterologous antikidney antibody, or antibody directed against antigen bound to glomerular basement membrane (8) (9) (10) (11) of the peripheral blood. This observation carries the implication that the IgG located on the glomerular tuft of the kidney does not involve nonspecific deposition of immunoglobulin from the immunoglobulin pool, but rather that the immunoglobulin on the glomerular membranes is derived from antibody. This is especially clear in the cases of anaphylactoid purpura nephritis and Goodpasture's syndrome, in which, with one exception, there was staining with antisera directed against only one of the light chains. Absence of fluorescent staining for a particular antigen in a tissue may be due to absence of the antigen, its presence in quantities too small to be detected 1w immunofluorescent methods, or the lack of availability of antigenic sites to react with the specific fluoresceinconjugated antibody. Since there is no evidence in human renal disease for the third possibility, we have concluded that the lack of staining indicates that the antigen is not present at all or is present in very minute amounts. The demonstration of one light chain and not the other in the deposited IgG is presumptive evidence that this IgG is a special part rather than a nonspecific sample of the host IgG. Since individual plasma cells are known to produce y-globulin of only one light chain type (15) , it is possible that a clone of cells and its descendants may have been selectively stimulated to produce the specific IgG seen on the kidney at any particular time.
